Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Bioorganic & Medicinal Chemistry
|
October 11, 2005
Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors
Kristopher G Virga, Yong-Mei Zhang, Roberta Leonardi, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 16, 2016
Leading Causes of Cancer Mortality - Caribbean Region, 2003-2013
Hilda Razzaghi, Sarah Quesnel-Crooks, Recinda Sherman, et al.
Molecular Endocrinology (Baltimore, Md.)
|
June 1, 2014
PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes
Mini P Sajan, Robert A Ivey, Mackenzie Lee, et al.
Journal of Strength and Conditioning Research
|
December 9, 2016
Fat-Free Mass Index in NCAA Division I and II Collegiate American Football Players
Eric T Trexler, Abbie E Smith-Ryan, Malia N M Blue, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
January 22, 2024
COPD in Never-Smokers: BOLD Australia Study
Marsha A Ivey, Sheree M Smith, Geza Benke, et al.
Leukemia
|
December 11, 2012
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
C Craddock, L Quek, N Goardon, et al.
American Heart Journal
|
August 25, 2015
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy
Christopher M Kramer, Evan Appelbaum, Milind Y Desai, et al.
Blood
|
January 15, 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
C D DiNardo, I S Tiong, A Quaglieri, et al.
Leukemia
|
July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J V Jovanovic, A Ivey, A M Vannucchi, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Bioorganic & Medicinal Chemistry
|
October 11, 2005
Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors
Kristopher G Virga, Yong-Mei Zhang, Roberta Leonardi, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 16, 2016
Leading Causes of Cancer Mortality - Caribbean Region, 2003-2013
Hilda Razzaghi, Sarah Quesnel-Crooks, Recinda Sherman, et al.
Molecular Endocrinology (Baltimore, Md.)
|
June 1, 2014
PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes
Mini P Sajan, Robert A Ivey, Mackenzie Lee, et al.
Journal of Strength and Conditioning Research
|
December 9, 2016
Fat-Free Mass Index in NCAA Division I and II Collegiate American Football Players
Eric T Trexler, Abbie E Smith-Ryan, Malia N M Blue, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
January 22, 2024
COPD in Never-Smokers: BOLD Australia Study
Marsha A Ivey, Sheree M Smith, Geza Benke, et al.
Leukemia
|
December 11, 2012
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
C Craddock, L Quek, N Goardon, et al.
American Heart Journal
|
August 25, 2015
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy
Christopher M Kramer, Evan Appelbaum, Milind Y Desai, et al.
Blood
|
January 15, 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
C D DiNardo, I S Tiong, A Quaglieri, et al.
Leukemia
|
July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J V Jovanovic, A Ivey, A M Vannucchi, et al.
Page
of 6